NM_002633.3:c.*93A>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002633.3(PGM1):​c.*93A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.191 in 949,000 control chromosomes in the GnomAD database, including 18,877 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2651 hom., cov: 32)
Exomes 𝑓: 0.19 ( 16226 hom. )

Consequence

PGM1
NM_002633.3 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.192

Publications

25 publications found
Variant links:
Genes affected
PGM1 (HGNC:8905): (phosphoglucomutase 1) The protein encoded by this gene is an isozyme of phosphoglucomutase (PGM) and belongs to the phosphohexose mutase family. There are several PGM isozymes, which are encoded by different genes and catalyze the transfer of phosphate between the 1 and 6 positions of glucose. In most cell types, this PGM isozyme is predominant, representing about 90% of total PGM activity. In red cells, PGM2 is a major isozyme. This gene is highly polymorphic. Mutations in this gene cause glycogen storage disease type 14. Alternativley spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Mar 2010]
PGM1 Gene-Disease associations (from GenCC):
  • PGM1-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-63659768-A-C is Benign according to our data. Variant chr1-63659768-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 297897.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.276 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PGM1NM_002633.3 linkc.*93A>C 3_prime_UTR_variant Exon 11 of 11 ENST00000371084.8 NP_002624.2 P36871-1
PGM1NM_001172818.1 linkc.*93A>C 3_prime_UTR_variant Exon 11 of 11 NP_001166289.1 P36871-2B7Z6C2
PGM1NM_001172819.2 linkc.*93A>C 3_prime_UTR_variant Exon 11 of 11 NP_001166290.1 P36871-3B4DDQ8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PGM1ENST00000371084.8 linkc.*93A>C 3_prime_UTR_variant Exon 11 of 11 1 NM_002633.3 ENSP00000360125.3 P36871-1
PGM1ENST00000650546.1 linkc.*149A>C 3_prime_UTR_variant Exon 12 of 12 ENSP00000497812.1 A0A3B3ITK7
PGM1ENST00000371083.4 linkc.*93A>C 3_prime_UTR_variant Exon 11 of 11 2 ENSP00000360124.4 P36871-2
PGM1ENST00000540265.5 linkc.*93A>C 3_prime_UTR_variant Exon 11 of 11 2 ENSP00000443449.1 P36871-3

Frequencies

GnomAD3 genomes
AF:
0.174
AC:
26500
AN:
152054
Hom.:
2651
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0890
Gnomad AMI
AF:
0.163
Gnomad AMR
AF:
0.282
Gnomad ASJ
AF:
0.149
Gnomad EAS
AF:
0.213
Gnomad SAS
AF:
0.180
Gnomad FIN
AF:
0.277
Gnomad MID
AF:
0.161
Gnomad NFE
AF:
0.183
Gnomad OTH
AF:
0.201
GnomAD4 exome
AF:
0.195
AC:
155065
AN:
796828
Hom.:
16226
Cov.:
11
AF XY:
0.194
AC XY:
80979
AN XY:
418038
show subpopulations
African (AFR)
AF:
0.0810
AC:
1671
AN:
20620
American (AMR)
AF:
0.332
AC:
13110
AN:
39516
Ashkenazi Jewish (ASJ)
AF:
0.147
AC:
3182
AN:
21592
East Asian (EAS)
AF:
0.193
AC:
6828
AN:
35288
South Asian (SAS)
AF:
0.191
AC:
13407
AN:
70228
European-Finnish (FIN)
AF:
0.266
AC:
13480
AN:
50730
Middle Eastern (MID)
AF:
0.155
AC:
704
AN:
4556
European-Non Finnish (NFE)
AF:
0.184
AC:
95104
AN:
515902
Other (OTH)
AF:
0.197
AC:
7579
AN:
38396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
5700
11400
17100
22800
28500
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2040
4080
6120
8160
10200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.174
AC:
26519
AN:
152172
Hom.:
2651
Cov.:
32
AF XY:
0.179
AC XY:
13350
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.0889
AC:
3695
AN:
41544
American (AMR)
AF:
0.283
AC:
4323
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.149
AC:
517
AN:
3470
East Asian (EAS)
AF:
0.213
AC:
1099
AN:
5166
South Asian (SAS)
AF:
0.178
AC:
860
AN:
4820
European-Finnish (FIN)
AF:
0.277
AC:
2931
AN:
10566
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.183
AC:
12470
AN:
68004
Other (OTH)
AF:
0.202
AC:
427
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1094
2188
3283
4377
5471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.179
Hom.:
8315
Bravo
AF:
0.172
Asia WGS
AF:
0.197
AC:
684
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 38% of patients studied by a panel of primary immunodeficiencies. Number of patients: 36. Only high quality variants are reported. -

Congenital disorder of glycosylation Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PGM1-congenital disorder of glycosylation Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
9.7
DANN
Benign
0.67
PhyloP100
0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4643; hg19: chr1-64125439; API